QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.

Name: QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.
License: Public Domain

Sun Yat-Sen University Cancer Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

nasopharyngeal cancinoma (npc), nasopharyngeal cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 444869
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.